- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03589274
Testing CBT Models and Change Mechanisms for Alcohol Dependent Women (WTPIII)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants completed a telephone screen for initial eligibility and were scheduled for an in-person clinical intake interview. Consented women were scheduled for a baseline research interview (BL) approximately one week later. At the end of the BL, participants were randomized to treatment condition. During the 12 session treatment period, women completed assessments at the beginning and end of each therapy session on secondary outcome and therapy process variables.
In I-FS-CBT each participant saw a therapist weekly. The first session was 90 minutes long, and subsequent sessions were 60 minutes long. The I-FS-CBT manual included core CBT, motivational enhancement, and relapse prevention components. Two core thematic women's issues were integrated into each session via discussion and illustrative material: (a) self-confidence and (b) self-care.
The G-FS-CBT manual included material identical to I-FS-CBT, but the session organization was modified for a closed group format. The group treatment was designed to provide didactic presentation of coping skills and motivational enhancement material, and group discussion and rehearsal of new skills within a supportive atmosphere that facilitated mutual emotional support and support for abstinence. The first session of G-FS-CBT was 2 hours; remaining sessions were 90 minutes.
In-person follow-up interviews were done at 3, 9, and 15 months post-session 1.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 18 or older
- have a current (past year) Diagnostic and Statistical Manual-IV (DSM-IV) alcohol dependence diagnosis
- used alcohol in the 60 days prior to telephone screening
Exclusion Criteria:
- have psychotic symptoms in the past six months
- gross cognitive impairment
- current physiological dependence on any illicit drug
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: I-FS-CBT
In I-FS-CBT each participant saw a therapist weekly.
The first session was 90 minutes long, and subsequent sessions were 60 minutes long.
The I-FS-CBT manual included core CBT, motivational enhancement, and relapse prevention components.
Two core thematic women's issues were integrated into each session via discussion and illustrative material: (a) self-confidence, and (b) self-care.
|
12 manual-guided sessions of I-FS-CBT
|
|
Experimental: G-FS-CBT
The G-FS-CBT manual included core CBT, motivational enhancement, and relapse prevention components.
Two core thematic women's issues were integrated into each session via discussion and illustrative material: (a) self-confidence, and (b) self-care.
The session organization was modified for a closed group format.
The group treatment was designed to provide didactic presentation of coping skills and motivational enhancement material, and group discussion and rehearsal of new skills within a supportive atmosphere that facilitated mutual emotional support and support for abstinence.
|
12 manual-guided sessions of G-FS-CBT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent Drinking Days (PDD)
Time Frame: Change from baseline across 15 months post-session 1
|
Derived from Timeline Followback (TLFB)
|
Change from baseline across 15 months post-session 1
|
|
Percent Heavy Drinking Days (PHDD)
Time Frame: Change from baseline across 15 months post-session 1
|
Derived from TLFB; Defined as 4 or more standard drinks per day
|
Change from baseline across 15 months post-session 1
|
|
Mean Drinks Per Drinking Day (MDPDD)
Time Frame: Change from baseline across 15 months post-session 1
|
Derived from TLFB
|
Change from baseline across 15 months post-session 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Beck Depression Inventory II
Time Frame: Baseline and through study completion, about 15 months
|
self-report questionnaire assessing depression symptoms over the prior two weeks (scores range 0-63) and higher scores indicate greater depression symptomatology.
All item scores are summed to attain a total score.
|
Baseline and through study completion, about 15 months
|
|
Anxiety
Time Frame: Baseline and through study completion, about 15 months
|
Assessed anxiety symptoms in the last week (scores range 0-63) with higher scores indicating higher anxiety symptomatology.
Item scores summed to attain total score.
|
Baseline and through study completion, about 15 months
|
|
Sociotropy-Autonomy Scale
Time Frame: Baseline and through study completion, about 15 months
|
Measures the extent of an individual's concern with others' opinion of herself (sociotropy) and self-confidence, behavioral and emotional independence (autonomy).
Sociotropy sub scale ranges from 0 to 64 with higher scores indicating higher sociotropy.
Average Sociotropy Scores are attained by averaging items, with total scores from 0 to 4. Autonomy sub scale Score range from 0 to 44 with higher scores indicating greater autonomy.
Average Autonomy Scores are attained by averaging items, with total scores from 0 to 4.
|
Baseline and through study completion, about 15 months
|
|
Coping Strategies Scale
Time Frame: Baseline and through study completion, about 15 months
|
Assessed use frequency of 30 strategies to cope with alcohol use and non-alcohol related situations, on a scale of 1 (never) to 4 (frequently) for a mean score across all items
|
Baseline and through study completion, about 15 months
|
|
Situational Confidence Scale 8
Time Frame: Baseline and through study completion, about 15 months
|
Measured self-efficacy to abstain from alcohol use in high-risk situations; each item is rated 0% to 100% for a global confidence score.
|
Baseline and through study completion, about 15 months
|
|
Important People Inventory
Time Frame: Baseline and through study completion, about 15 months
|
Assessed social network structure, network drinking, and network response to drinking and abstinence.
Percentage of network accepting/encouraging abstinence and percentage of network abstainers/in recovery were used.
|
Baseline and through study completion, about 15 months
|
|
Self care
Time Frame: Baseline and through study completion, about 15 months
|
Assessed 8 domains of self-care: seek medical care, have free time, pleasurable activities, social contact, attend treatment, exercise, do nice things for oneself, buy nice things for oneself
|
Baseline and through study completion, about 15 months
|
|
Inventory of Personal Problems
Time Frame: Baseline and through study completion, about 15 months
|
Assessed problems in 10 interpersonal domains, rated on a 0 to 4 scale.
A total sum score was used for this study; higher scores reflect more interpersonal problems
|
Baseline and through study completion, about 15 months
|
|
Group Environment Scale Form R
Time Frame: Baseline and through study completion, about 15 months
|
Measured 10 group process subscales (e.g., Cohesiveness, Leader Support, Order/Organization, Expressiveness, Anger/Aggression), each with a mean scale score for 4 items rated on a 0-4 scale.
|
Baseline and through study completion, about 15 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
End of Treatment Questionnaire
Time Frame: 3 months post session 1
|
Measured client ratings of helpfulness of therapy elements on a 7 point scale of -3 (greatly harmful), -2, -1, 0 (neutral), +1, +2, +3 (greatly helpful).
|
3 months post session 1
|
|
Working Alliance Inventory - Short Form
Time Frame: Weekly during Treatment, about 15 weeks
|
12-item self-report measure of the therapeutic alliance (7-point scale with a total possible score of 84)
|
Weekly during Treatment, about 15 weeks
|
|
Therapy Integrity Rating Scale
Time Frame: Weekly during treatment, about 15 weeks
|
39 five-point Likert scale items to assess domains common to both treatment conditions (e.g., general interventions, female-specific interventions, common factors) and unique to a single treatment condition (e.g., group therapy interventions)
|
Weekly during treatment, about 15 weeks
|
|
Therapist Checklist
Time Frame: Weekly during Treatment, about 15 weeks
|
Coding treatment components delivered in each session from 3 to 0 as thoroughly, moderately, minimally, or not covered
|
Weekly during Treatment, about 15 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Elizabeth E Epstein, PhD, Rutgers, The State University of New Jersey
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 03-346R08x
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use Disorder
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Methamphetamine-dependence | Substance Use Disorders | Cocaine Use Disorder | Alcohol Use Disorder (AUD) | Cannabis Use Disorder | Amphetamine Use DisorderGermany
-
Washington State UniversityRecruitingNicotine Use Disorder | Alcohol Use Disorder (AUD)United States
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
University of North Carolina, Chapel HillCompletedAlcohol Use Disorder, Mild | Alcohol Use Disorder, ModerateUnited States
-
University of BernRecruitingAlcohol Use Disorder (AUD) | Substance Use Disorder (SUD) | Cocaine Use Disorder (CUD)Switzerland
-
Université du Québec à Trois-RivièresCompletedAlcohol Use, Unspecified | Alcohol Use Disorder, MildCanada
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of Wisconsin, MadisonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingAlcohol Use Disorder | Alcohol Use Disorder (AUD)United States
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Substance Use Disorders | Alcohol Use Disorder (AUD)Germany
-
University of Notre DameNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingAlcohol Use | Opioid Use Disorder | Alcohol Use Disorder | Opioid UseUnited States
Clinical Trials on I-FS-CBT
-
Chinese University of Hong KongRecruiting
-
VA Office of Research and DevelopmentVA Finger Lakes Healthcare SystemTerminated
-
Indiana UniversityIndiana Clinical and Translational Sciences InstituteTerminatedChronic Pain | InsomniaUnited States
-
Noctem, LLCUnited States Naval Medical Center, San Diego; Naval Health Research CenterRecruitingInsomnia | TBI (Traumatic Brain Injury)United States
-
University of ArizonaAmerican Academy of Sleep MedicineUnknown
-
The University of Hong KongChinese University of Hong Kong; Stanford University; Goldsmiths, University...Active, not recruitingInsomnia | AnxietyHong Kong
-
VA Office of Research and DevelopmentCompletedInsomnia | Traumatic Brain InjuryUnited States
-
University of California, Los AngelesCompletedInsomnia ChronicUnited States
-
VA Office of Research and DevelopmentTerminatedSleep Initiation and Maintenance Disorders | Marijuana AbuseUnited States
-
St. Olavs HospitalCompleted